Name: GeneDx Holdings Corp. (WGS) Financial Statements
Creator: FinSpry

GeneDx Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

GeneDx Holdings Corp. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	305.45	202.57	234.69	212.20	179.32
Cost of Revenue	111.05	116.06	261.44	228.80	155.73
Gross Profit	194.40	86.51	-26.75	-16.60	23.60
Operating Expenses
Research & Development	45.72	55.09	86.20	105.16	72.70
Selling, General & Administrative	168.48	191.49	338.24	318.73	173.32
Operating Expenses	217.61	251.85	430.76	429.55	246.02
Operating Income	-23.21	-165.34	-457.51	-446.15	-222.42
Other Income/Expense
Interest Income	0.00	1.11	2.54	0.08	0.51
Interest Expense	3.03	0.00	-0.67	2.84	-2.47
Other Income/Expense	-26.38	1.17	70.29	203.52	0.02
Income
Income Before Tax	-52.63	-176.69	-598.03	-245.39	-241.34
Income Tax Expense	-0.34	-0.93	-49.05	0.00	0.00
Net Income	-52.29	-175.77	-548.98	-245.39	-241.34
Net Income - Continuous Operations	-52.29	-175.77	-548.98	-245.39	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-1.26	-138.21	-413.60	-220.75	-213.69
EBIT	-23.21	-165.34	-457.51	-242.56	-222.42
Depreciation & Amortization	21.95	27.13	43.91	21.81	8.73
Earnings Per Share
Basic EPS	-2.00	-7.00	-54.00	-75.00	-
Diluted EPS	-2.00	-7.00	-54.00	-75.00	-
Basic Shares Outstanding	26.89	24.31	10.24	3.28	0.00
Diluted Shares Outstanding	26.89	24.31	10.24	3.28	0.00